mifepristone has been researched along with sc 560 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Cano, A; García-Martínez, MC; García-Pérez, MA; Hermenegildo, C; Oviedo, PJ; Tarín, JJ | 1 |
Cano, A; García-Pérez, MA; Hermenegildo, C; Laguna-Fernandez, A; Novella, S; Oviedo, PJ; Rius, C; Sobrino, A; Tarín, JJ | 1 |
4 other study(ies) available for mifepristone and sc 560
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Progestogens stimulate prostacyclin production by human endothelial cells.
Topics: Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Epoprostenol; Estradiol; Humans; Medroxyprogesterone Acetate; Membrane Proteins; Mifepristone; Nitrobenzenes; Progesterone; Progestins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Receptors, Progesterone; Sulfonamides; Umbilical Veins | 2005 |
Progestogens reduce thromboxane production by cultured human endothelial cells.
Topics: Antineoplastic Agents, Hormonal; Blotting, Western; Cells, Cultured; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Endothelial Cells; Gene Expression; Hormone Antagonists; Humans; Intramolecular Oxidoreductases; Medroxyprogesterone Acetate; Mifepristone; Polymerase Chain Reaction; Progesterone; Progestins; Pyrazoles; RNA, Messenger; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Umbilical Veins | 2011 |